Glucagon-like peptide-1 (GLP-1) agonists are a class of medications primarily used to manage type 2 diabetes mellitus and, more recently, obesity
10.1016/j.diabres.2019.107892 21 NakataniY.MaedaM.MatsumuraM.ShimizuR.BanbaN.AsoY.et al (2017)
Once reconstituted with bacteriostatic water, the solution should be refrigerated at 28C and used within the timeframe indicated on the product COA
Early pharmaceutical development efforts, therefore, prioritized selective MC4R agonism over MC3R, a decision guided by rodent studies utilizing genetic data, knockout models, and studies with melanocortin ligands
Tirzepatide has already completed this journey twice, earning approval for type 2 diabetes (Mounjaro, 2022) and chronic weight management (Zepbound, 2023)